BioHarmony Drug Data Store FAQs

BioHarmony FAQs Page graphic

Frequently Asked Questions...

  1. Where/how does BioHarmony get the data for its reports?
  2. What makes BioHarmony different from other drug databases?
  3. Can I subscribe to the entire database of drug reports?
  4. How does BioHarmony price reports for subscribers? Can we receive bulk discounting?
  5. Can I integrate my proprietary data with the public data collected by BioHarmony?
  6. Can I request additional information to be added to the individual BioHarmony drug reports?
  7. Can I search across the BioHarmony database for specific drug targets or disease information?
  • 1

    Where/how does BioHarmony get the data for its reports?

    BioHarmony searches the semantic (machine-readable) web to identify and consolidate the wealth of clinical and economic information that is available for prescription drugs.  Hundreds of validated databases exist, each containing unique information regarding agency approved drug use, the biological drug target, clinical features of the targeted disease, or drug revenue.  By leveraging semantic identifiers, BioHarmony interconnects reliable databases to extract, consolidate, and standardize existing information into a single, machine-readable, and artificial intelligence (AI)-ready report. Algorithms are run daily, ensuring reports contain the latest information.  A visual representation of the different sources we search and extract information from is shown in the semantic network graph below.

Example of BioHarmony’s semantic network graph. Blue and orange circles represent data sources; green circles indicate the information extracted from each source. Gray circles represent unambiguous, semantic identifiers that can be used to connect information across multiple data sources.

Jump to Another FAQ  

  • 2

    What makes BioHarmony different from other drug databases?

    1. Harmonization across all stages of the discovery pipeline.  No matter your position in the pipeline - preclinical, clinical, or post-approval, BioHarmony captures information that will improve your models and decisions.  BioHarmony provides a reliable and holistic view by including the following information:
      1. Drug target information: BioHarmony provides regulatory agency-approved targets identified in product labeling as well as alternative targets supported by multiple research articles.
      2. Research landscape: BioHarmony provides a summary of the timeline and frequency of publications related to a drug as well as related trending concepts extracted from open-access publications.
      3. Clinical trial information: BioHarmony provides a list of clinical studies that evaluated the drug of interest divided by phase of development.
      4. Patent information: BioHarmony provides expected patent expiry dates and links to relevant published patents.
      5. Claims reimbursement: BioHarmony provides details about drug classifications and indications, linking each to established claims codes, including the Anatomical Therapeutic Chemical (ATC), International Classification of Diseases - 10th revision (ICD-10), and Healthcare Common Procedure Coding System (HCPCS).
      6. Drug revenue reports: BioHarmony provides annual and quarterly revenue reports from key drug manufacturers.
    2. Real-time details. Algorithms are run daily ensuring that you have accurate and up-to-date trends. By purchasing access to a drug report, you subscribe to a full year of reports -- that’s 365 reports per drug!
    3. Accurate, curated data. Data in BioHarmony is checked periodically by experts in biology and chemistry to ensure accuracy.
    4. Machine Readable. Designed for use in modeling and informatics, our data is provided in a machine-readable format, complete with linked semantic identifiers.
    5. Captured Metadata. BioHamony’s proprietary technology traverses both structured databases and unstructured data sources. We automatically convert the valuable data from these unstructured resources (metadata) into a machine-readable format allowing you to incorporate it into your machine-learning models.

Jump to Another FAQ  

  • 3

    Can I subscribe to the entire database of drug reports?

    Yes! Drug reports are available as individual reports, as a focused group of linked drug reports (e.g, COVID-19 drug data set), and as a subscription to our entire catalogue.

Jump to Another FAQ  

  • 4

    How does BioHarmony price reports for subscribers? Can we receive bulk discounting?

    BioHarmony provides a convenient webstore interface for you to purchase annual subscription access to Drug Reports, and you have a variety of ways to purchase reports “in bulk” and save money!

    Custom Data Sets

    You can create your own shopping cart of reports, and quantity discounting will be automatically applied at checkout.  Below is a quick reference table of pricing for some sizes of custom sets:

       
    Number of ReportsDiscountNet Price
    10%$ 4,995
    540%$ 14,985
    1045%$ 27,472
    2560%$ 49,950

    If you have multiple custom sets you would like to purchase, please reach out to us at [email protected] for assistance.

    Curated Data Sets

    We have created a number of Curated Sets of drug reports that are frequently requested and have implemented special pricing for these common groupings.  Examples include:

       
    Curated Data SetNumber of Reports
    (April 2021)    		Net Price
    Top Revenue Generating Drugs17$ 14,995
    FDA 2020 Drug Approvals30$ 29,995
    COVID-19 Potential Thereapeutics46$ 29,995

    If you have a set of reports that you think would make a good Curated Set for the BioHarmony website, please reach out to us at [email protected] and we’d love to discuss options.

    Complete BioHarmony Catalog

    You can subscribe to BioHarmony’s ever-expanding catalog of drug reports for a fixed fee of $79,995 annually. This includes access to the complete BioHarmony collection and all Curated Data Sets.

    Please click here for complete catalog access or contact us at [email protected] for more details.

    BioHarmony for your organization – Teams, Sites, and Companies

    We offer convenient and scalable BioHarmony access pricing for groups of all sizes – from small teams to entire organizations.  Please contact us at [email protected] for more information.

Jump to Another FAQ  

  • 5

    Can I integrate my proprietary data with the public data collected by BioHarmony?

    Yes! For secure enterprise solutions and to discuss your specific needs, contact us at [email protected].

Jump to Another FAQ  

  • 6

    Can I request additional information to be added to the individual BioHarmony drug reports?

    BioHarmony is developed with an agile approach.  We listen to our customer feedback and prioritize the most frequently requested features. If there is additional data you would like to see in BioHarmony contact us at [email protected].

Jump to Another FAQ  

  • 7

    Can I search across the BioHarmony database for specific drug targets or disease information?

    Absolutely! The search feature on the BioHarmony homepage and on the Drug Data Store supports many types of keywords, including active ingredients, diseases, drug classes, companies, protein names and gene symbols, MeSH identifiers, ICD-10 codes, ATC codes, and more. BioHarmony will indicate which available reports are relevant to your particular search term.

Jump to Another FAQ